echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > New discovery! The body's stress hormones may promote the recovery of dormant cancer cells causing the cancer to return

    New discovery! The body's stress hormones may promote the recovery of dormant cancer cells causing the cancer to return

    • Last Update: 2020-12-11
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Now that medical scientists have been trying for years to understand why cancerous tumors sometimes relapse years after initial successful treatment, researchers have found evidence that cancer recurrence occurs when dormant cancer cells are awakened by stress hormones in the patient's body.
    Previous studies have shown that when cancerous tumors begin to grow, some cells move to other nearby locations and go into a dormant state, which seems unlikely to be killed or removed by surgery or chemotherapy because they are far away and dormant.
    Previous studies have shown that dormant cells such as these suddenly wake up and begin to grow into new tumors, sometimes even years after treatment; the paper explains the molecular mechanisms by which dormant cancer cells resuscitate, which are blamed on the body's stress hormones, such as epinephrine.
    By injecting these hormones into mice carrying dormant cancer cells and observing how they resuspension and how they began to multiply, the researchers also found that mice tested were less likely to form new tumors from the cancer cells that woke up if given β blockers, which reduce the protein levels expressed by the hormone.
    In addition, the researchers collected serum samples from the bodies of 80 lung cancer patients who had under surgery to remove the tumor, and found that patients carrying high levels of S100A8/A9, a protein released by epinephrine, may be more likely to develop new tumors.
    Finally, the researchers say giving cancer patients β blockers may be an effective way to prevent the recurrence of certain types of cancer, and that drugs specifically blocking the production of S100A8/A9 may be a better treatment.
    source: Michela Perego, Vladimir A. Tyurin, Yulia Y. Tyurina, et al. Reactivation of dormant tumor cells by modified lipids derived from stress-activated neutrophils, Science Translational Medicine (2020). DOI: 10.1126/scitranslmed.abb5817。
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.